moderately significantp < 0.05
Post hoc comparisons revealed that the microdosing group had a moderately significant improvement in CMJ (g = 0.66, p < 0.05), a very significant improvement in RSI (g = 0.96, p < 0.01), and a moderately significant benefit in RSImod (g = 0.71, p < 0.05) compared to the control group.